enkephalinamide-met, ala(2)- has been researched along with selegiline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dzoljic, M; Haffmans, J; Ukponmwan, OE; van der Poel-Heisterkamp, AL | 1 |
1 other study(ies) available for enkephalinamide-met, ala(2)- and selegiline
Article | Year |
---|---|
MAO-B inhibitor deprenyl and beta-phenylethylamine potentiate [D-ALA2]-Met-enkephalinamide-induced seizures.
Topics: 2-Hydroxyphenethylamine; Animals; Drug Synergism; Electroencephalography; Electromyography; Enkephalin, Methionine; Male; Phenethylamines; Rats; Rats, Inbred Strains; Seizures; Selegiline | 1983 |